SEARCH WITHIN CONTENT
Citation Information : Polish Journal of Microbiology. Volume 66, Issue 4, Pages 543-545, DOI: https://doi.org/10.5604/01.3001.0010.7103
License : (CC BY-NC-ND 4.0)
Received Date : 02-March-2017 / Accepted: 17-May-2017 / Published Online: 04-December-2017
The aim of this study was to analyze the seroprevalence of rubella and cytomegalia among young women. The study included 175 healthy women from the Biała Podlaska District, aged 16 to 35 years. Anti-rubella and anti-CMV IgG were determined by ELISA. 172 (98.3%) study subjects tested positive for rubella antibodies, 1 (0.6%) was seroindeterminate and 2 (1.1%) were seronegative. CMV antibodies were detected in 119 (68.0%) participants; the series included also 1 (0.6%) seroindeterminate and 55 (31.4%) seronegative women. The levels of rubella and CMV antibodies were not significantly affected by age, place of residence and educational level of the study subjects.
Cannon M.J., D.S. Schmid and T.B. Hyde. 2010. Reviev of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20: 202–213.
Czarkowski M.P., B. Kondej, E. Staszewska-Jakubik and E. Cie-lebąk. 2016. Vaccinations in Poland in 2015 (in Polish). http://wwwold.pzh.gov.pl/oldpage/epimeld/2015/Sz_2015.pdf. 2017.01.16.
European Centre for Disease Prevention and Control. 2016. Measles and rubella monitoring, July 2016 – Disease surveillance data: 1 July 2015 – 30 June 2016. Stockholm: ECDC. https://ecdc.europa.eu/en/publications/Publications/measles-rubella-monitoring-july-2016.pdf. 2017.01.16.
Gaj Z., M. Rycel, J. Wilczyński and D. Nowakowska. 2012. Seroprevalence of cytomegalovirus infection in the population of Polish pregnant women. Ginekol. Pol. 83: 337–341.
Hamilton S.T., W. van Zuylen, A. Shand, G.M. Scott, Z. Naing,B. Hall, M.E. Craig and W.D. Rawlinson. 2014. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev. Med. Virol. 24: 420–433.
Kadambari S., E.J. Williams, S. Luck, P.D. Griffihs and M. Sharland. 2011. Evidence based management guidelines for the detection and treatment of congenital CMV. Early Hum. Dev. 87: 723–728.
Lambert N., P. Strebel, W. Orenstein, J. Icenogle and G.A. Poland. 2015. Rubella. Lancet 385: 2297–2307.
Ludwig A. and H. Hengel. 2009. Epidemiological impact anddisease burden of congenital cytomegalovirus infection in Europe. Euro Surveill. 14(9): 26–32.
Murray P.R., K.S. Rosenthal and M.A. Pfaller. 2011. Microbiology (in Polish). Elsevier Urban & Partner, Wrocław.
Siennicka J., M. Dunal-Szczepaniak, A. Trzcińska, P. Godzik and M. Rosińska. 2016. High seroprevalence of CMV among women of childbearing age implicates high burden of congenital cytomegalovirus infection in Poland. Pol. J. Microbiol. 65: 425–432.
Smits G., L. Mollema, S. Hahné, H. de Melker, I. Tcherniaevaa,F. van der Klis and G. Berbe. 2014 Seroprevalence of rubella antibodies in the Netherlands after 32 years of high vaccination cover-age. Vaccine 32: 1890–1895.
Wujcicka W., Z. Gaj, J. Wilczyński, W. Sobala, E. Śpiewak andD. Nowakowska. 2014. Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur. J. Clin. Microbiol. Infect. Dis. 33: 1951–1958.
Wysokińska T., W. Janaszek, B. Bucholc, P. Gorska, G. Gniadek, J. Slusarczyk and M. Rawicz. 2004 The prevalence of anti-rubella antibodies in women of childbearing age in Poland. Vaccine 22: 1899–1902.
Zimmerman L., J. Rogalska, K.A. Wannemuehler, M. Haponiuk,A. Kosek, E. Pauch, E. Plonska, D. Veltze, M.P. Czarkowski,N. Buddh and others. 2011. Toward Rubella elimination in Poland: Need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts. JID 204(Suppl 1): 389–395.